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ABSTRACT 
 
Suppression of gene expression by small interfering RNA (siRNA) has proved to be a gene-specific and cost effective 
alternative to other gene suppression technologies. Short hairpin RNAs (shRNAs) generated from the vector-based 
expression are believed to be processed into functional siRNAs in vivo, leading to gene silencing. Since an shRNA 
library carries a large pool of potential siRNAs, such a library makes it possible to knock down gene expression at the 
genome wide scale. Although much of research has been focused on generating shRNA libraries from either 
individually made gene specific sequences or cDNA libraries, there is no report on constructing randomized shRNA 
libraries, which could provide a good alternative to these existing libraries. We have developed a method of 
constructing shRNAs from randomized oligonucleotides. Through this method, one can generate a partially or fully 
randomized shRNA library for various functional analyses. We validated this procedure by constructing a p53-specific 
shRNA. Western blot revealed that the p53-shRNA successfully suppressed expression of the endogenous p53 in MCF-
7 cells. We then made a partially randomized shRNA library. Sequencing of 15 randomly picked cloned confirmed the 
randomness of the library. Therefore, the library can be used for various functional assays, such as target validation 
when a suitable screening or selection method is available. 
 
   
INTRODUCTION  Because of its simplicity, effectiveness, specificity, and 
easy adaptation to high throughput, this technology 
holds enormous scientific, commercial, and therapeutic 
potential.  
 
The recent development of short interfering RNA 
(siRNA) technology based on RNA interference (RNAi) 
enables the functional knock down of all genes in a 
systematic manner. RNAi is the mechanism of sequence-
specific gene silencing by either the specific degradation 
of homologous mRNAs or transcription-mediated gene 
suppression (1-4). siRNAs are a new class of nucleic-acid-
based gene-silencing molecule that could be more potent 
than ribozymes and antisense oligonucleotides in 
silencing gene expression because they use cellular 
machinery (5). Moreover, siRNA technology is more cost 
effective and efficient to create loss-of-function 
phenotypes, compared to antisense and knockout techniques.  
 
In research laboratories, two types of siRNAs have been 
widely used to induce specific gene silencing. While 
synthetic siRNAs are made in vitro chemically or 
enzymatically (e.g., in vitro transcription-based method) 
(6, 7), vector-based siRNAs are usually transcribed 
through members of the type III class of Pol III 
promoters such as the H1 promoter and U6 promoter (8, 
9). Compared to synthetic siRNAs, vector-based siRNAs 
possess a unique feature that makes it possible to study 
gene silencing over a long period of time.     
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The majority of vector-based siRNAs are generated from 
short hairpin RNAs (shRNAs). In this system, a single 
Pol III promoter (e.g., H1 or U6) drives transcription of a 
single species of RNA molecule (8, 9) from a DNA 
fragment consisting of a 19-29 base pair stem with a 
tightly structured loop. Transcription of this highly 
structured fragment yields an shRNA, which is then 
processed into an siRNA through the conserved Dicer 
family of RNase III enzymes (10). Thus, the transcribed 
product mimics the synthetic siRNA duplex. Like the 
synthetic siRNA, the in vivo processed siRNA triggers 
mRNA degradation and gene silencing. In some cases, a 
double promoter system has also been used to drive 
vector-based siRNA expression, where two promoters 
are in tandem or in opposite directions (11-13). This 
system does not produce shRNAs; instead, siRNA is 
directly generated when two complementary RNA 
molecules come together and form a duplex, leading to 
gene silencing. 
 
Mounting evidence has suggested base preference for the 
siRNA-mediated gene silencing. For instance, less than 
50% of tested sequences of a gene are capable of 
generating functional siRNAs (14, 15). Therefore, 
selection of the right sequences is critical for gene 
silencing efficiency. Extensive studies have been done on 
selecting potential target sequences for siRNAs. Some 
guidelines have been suggested to increase the chance of 
success in silencing gene expression (16, 17). However, 
there are still no unified rules defining the functional 
siRNA sequences; different genes may have different 
sequence preferences. In many cases, functional siRNAs 
do not fall into these rules (18). Therefore, siRNAs 
derived from cDNA libraries would provide a good 
source to search for functional siRNAs because such 
libraries carry a variety of DNA sequences that would 
generate functional siRNAs.  
 
Elucidation of gene function is a major challenge in the 
post genomic era. The concept of the siRNA library has 
emerged to meet such a demand because the siRNA 
library allows for evaluation of gene function at the 
genome wide scale. For instance, a retrovirus-based 
shRNA library has been constructed carrying 9,610 
human and 5,563 mouse genes (19). However, although 
this approach is very attractive, generation of such a 
library is enormously time consuming and costly because 
potential siRNAs are designed and made individually 
against each gene. Therefore, an shRNA library made 
from cDNAs or cDNA libraries would offer a simple 
alternative to this approach (14, 15, 20). Although 
generation of these cDNA-based shRNA libraries is 
much more cost effective than an individually made 
gene-specific shRNA library, they still suffer from 
several limitations due to the inherited nature of cDNA 
libraries. For instance, not all genes are expressed in all 
tissues or cells; not all genes are expressed at the same 
level.   
 
Ideally, a good shRNA library should carry all possible 
sequences with equal amount of copies against any gene, 
be easy to construct and be cost effective. A randomized 
shRNA library would meet these criteria. Toward this 
end, we have developed a method to construct shRNAs 
from randomized oligonucleotides, by which one can 
relatively easily generate a randomized shRNA library. 
 
MATERIALS AND METHODS 
 
Cloning Strategy  
 
As shown in Fig. 1, the entire cloning procedure involves 
the following 4 steps.  
 
A: Incorporation of 19 randomized nucleotides into 
PCR products: Since a sequence carrying 19-29 
nucleotides has been shown to efficiently suppress its 
cognate genes (8, 21), we used a 19 base siRNA to 
illustrate how shRNAs can be generated from 
randomized oligonucleotides. First, we designed a 
primer that carries 19 randomized nucleotides, named R-
H1-siRNA-3.2, 5’-
AACACAAGTAGCTATCCATCTCGAGN19AGGGGAT
CCTGGTCTCATAC; part of its sequences is shown in 
Fig. 1 step A, as indicated by an arrow. This primer also 
carried other important features: 1) we introduced BamH 
I (GGATCC) at the end of the H1 promoter and before 
the potential transcription site for subsequent cloning 
and manipulations. 2) within the BamH I site was the 
N.Alw I recognized sequence (GGATCNNNN^N), 
which makes a single cut on the double-stranded DNA 
and allows for opening of the loop structure at step C. 
We have previously used this nick enzyme for 
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c o n s t r u c t i o n  o f  a n  s h R N A  l i b r a r y  f r o m  c D N A  ( 2 2 ) ;  3 )  
immediately after the randomized sequence was a 20 
base sequence, which carries the Bcc I site (CCATC4/5) 
(Fig. 1, step A). The Bcc I-digested end carried a 5’ G (in 
red) overhang, which was compatible with the siRNA-
loop-1 (step B). To incorporate this randomized 
oligonucleotide primer into the H1 promoter, we used it 
as an antisense PCR primer along with the sense primer 
H1-5.1, 5’-AGTGGCGCCCTGCAATATTTG. Thus, after 
PCR amplification, the randomized sequence was 
introduced into the PCR products; each molecule of the 
PCR products, in theory, would carry a unique sequence 
at the randomized sequences of the 3’ end, while the rest 
of sequences remain the same among all the molecules. 
Although we used the H1 promoter as an adaptor, any 
other DNA sequences should also work as long as they 
are compatible with the following steps. 
 
B: Ligation of siRNA-loop-1: siRNA-loop-1 is a 21 base 
oligonucleotide that forms a 7 bp stem with a 7 base 
loop. The loop sequence was derived from a published 
one (8), but in a complementary form. When this loop 
was opened, the sequence of the filled strand would be 
exactly the same as the one previously described (8). The 
7 bp stem of siRNA-loop-1 carried the Xho I site, which 
was designed to remove the loop in a later stage. The 5’ 
end of the oligonucleotide was phosphorylated to 
achieve efficient ligation. Thus, when it was self-
annealed, siRNA-loop-1 formed a phosphorylated C 
overhang, which was complementary to the Bcc I-
digested DNA fragment. 
 
C: Generation of palindromic sequences: This step 
consisted of nicking and extension. To cut the top DNA 
strand between the end of the H1 promoter and the 
beginning of the target sequence, we digested the DNA 
fragment with the nicking enzyme N.Alw I, (Fig. 1, step 
B). We then incubated the nicked DNA at 72°C for 10 
min. Because the upstream region from the nick was 
much larger than the downstream region (over 100 bp vs 
25 bp) and thermodynamics favored the opening of the 
downstream region from the nick, the DNA fragment 
became partially single-stranded at the 3’ end (Fig. 1 step 
C). This partially double/single-stranded structure was 
essential to convert cloned sequences into a palindromic 
structure. Taq polymerase converted the single-stranded 
DNA into double-stranded DNA in the presence dNTP, 
using the bottom strand as a template and the top strand 
as a primer. The extended product carried an extra 
nucleotide A, which was compatible with the Xcm I site 
in pSK-H1-Pu-X (see below).  
 
D: Cloning: To unidirectionally clone the potential DNA 
fragment for shRNAs, we digested the extended product 
w i t h  B a m H  I .  T h e  r e s u l t i n g  6 5  b p  f r a g m e n t  w a s  
subsequently cloned into pSK-H1-Pu-X at BamH I and 
Xcm I sites. Thus, this unidirectional cloning procedure 
not only provided easy ligation but also allowed for 
transcription of the sequence with the desired length, 
because the Pol III enzyme recognizes 5Ts as a 
terminator. Finally, ligated DNA was introduced into 
competent E. coli cells.  
 
PCR reactions and ligation  
 
PCR was performed to introduce the target sequence into 
PCR products as the following conditions: 1 cycle of 94°C 
for 3 min, 30 cycles of 94°C for 0.5 min, 52°C for 1 min 
and 72°C for 0.5 min, followed by extension at 72°C for 
10 min. The cloned H1 promoter DNA was used as a 
template. The PCR product was purified by PCR 
purification kit (Qiagen, Valencia, CA), then digested 
with Bcc I, and finally purified by PCR purification kit. 
To generate p53-specific shRNA, PCR was performed 
under the same conditions except that an antisense 
primer was p53-siRNA-3.1 
(AACACAAGTAGCTATCCATCTCGAGUGTAGATTA
CCACTGGAGTCUAGGGG ATCCTGGTCTCATAC) 
where the p53-specific sequence was underlined.  
 
A typical ligation reaction for siRNA-loop-1 was 
performed using Fast link ligation kit (Epicentre, 
Madison, WI) at 4°C overnight. The ligated DNA was 
separated in a 2% agarose gel and then purified using gel 
purification kit (Qiagen). 
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Fig. 1: Illustration of cloning strategy. A: Incorporation of 19 randomized nucleotides into PCR products. PCR reactions were performed using the cloned 
H1 promoter as a template and primers H1-5.1 and H1-R-3.2. B: Ligation of siRNA-loop-1. After PCR, the PCR product was digested with Bcc I and then 
ligated to siRNA-loop-1. C: Generation of palindromic sequences. Digestion with the nicking enzyme N.Alw I generated a partially single-stranded and 
double-stranded structure. At 72°C Taq polymerase converted the single-stranded DNA to double stranded DNA. D: Cloning. The extended product was 
digested with BamH I and then ligated to pSK-H1-Pu-X that had been digested with BamH I and Xcm I. 
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Construction of pSK-H1-Pu-X 
 
To facilitate the final cloning of the DNA fragment 
carrying a 19-bp palindromic sequence, we constructed 
pSK-H1-Pu-X. First, we introduced Xcm I site between 
Hind III and Kpn I at pSK by two self-complementary 
oligonucleotides 5’-
AGCTTUCCAUTATGATTTTUTGGUGGTAC and 5’-
AUGGTUATACTAAAAUACCUC where Xcm I 
recognition site was underlined. The two 
oligonucleotides were first heated at 94ºC for 5 min and 
then slowly cooled down to room temperature. The 
annealed oligonucleotides were subsequently ligated 
into pSK that was previously linearized by Hind III and 
Kpn I. The resulting plasmid pSK-X carried an Xcm I site, 
followed by 5Ts at 3’ region, serving a transcription 
terminator for the Pol III.  
 
To introduce the H1 promoter and puromycin resistance 
gene into pSK-X, we amplified this segment using 
pSUPER-retro (Oligoengine, Seattle, WA) as a template. 
The primers were H1-3.3, 5’-
GGATCCUTGGTCTCATACAGAACTTA, where a 
BamH I site (underlined) was introduced; and Pu-3.1 5’-
TCTAGAUTTGCCAAACCTACAGGTGGG, where an 
Xba I site (underlined) was introduced. After this 
fragment was cloned into pSK-X at XbaI and Bam H1 
sites, resulting plasmid pSK-H1-Pu-X would 
accommodate a DNA fragment that has a nucleotide A 
overhang at 3’ end and a BamH I site at the other end.  
 
Cell culture and transfection 
 
MCF-7 cells (American Type Cell Collection, Manassas, 
VA) were grown in RPMI medium (BioWhittaker, 
Walkersville, MD), supplemented with 10% FBS, 2 mM 
L-glutamine, 100 units of penicillin/ml and 100 ug 
streptomycin /ml (both from BioWhittaker). Cells were 
incubated at 37°C in a humidified chamber 
supplemented with 5% CO2. 
 
Plasmid DNAs carrying an appropriate sequence were 
introduced into MCF-7 cells by Optifect (Invitrogen, 
Carlsbad, CA) per the manufacturer’s protocol in a 6-
well plate. To determine the effect of p53-shRNA on 
expression of the endogenous p53, transfected MCF-7 
cells were treated with doxorubincin at 0.4 ug/ml for 16 
h. Cells were then harvested to extract total protein, 
which was quantified using a protein assay kit (Bio-Rad, 
Hercules, CA).  
 
Western blot 
 
Total protein was extracted and separated in 9% SDS-
PAGE. Suppression of p53 protein was determined by 
anti-p53 antibody (Oncogene Science, Cambridge, MA). 
Signals were detected by ECL detection system (Pierce, 
Rockford, IL) and images were captured in Fluo-Chem 
imager (Alpha Innotech, San Leandro, CA). 
 
Reagents and DNA sequencing 
 
Oligonucleotides were synthesized through commercial 
sources (Sigma Genosys, Woodlands, TX or IDT, 
Coralville, IA). Restriction and nicking enzymes were 
obtained from New England Biolabs (Beverly, MA). Taq 
polymerase was purchased from ABI (Foster City, CA). 
DNA sequencing service was provided by Northwoods 
DNA (Solway, MN). 
 
RESULTS AND DISCUSSION 
 
To determine whether functional shRNAs can be 
generated through this approach, we constructed a 
vector-based p53-shRNA following the strategy outlined 
in Fig. 1. To incorporate half of p53 shRNA palindromic 
sequence 5’-GACTCCAGTGGTAATCTAC (8) into PCR 
products, we used a sense primer, H1-5.1, and an 
antisense primer, p53-siRNA-3.1 (see Materials and 
Methods). Primer p53-siRNA-3.1 differed from R-H1-
siRNA-3.2 in that the 19 base p53 sequence (8) replaced 
the 19 base randomized oligonucleotides of R-H1-
siRNA-3.2. The amplified fragment was about 150 bp 
(Fig. 2A, lane 1). Following digestion with Bcc I, the 
digested fragment was 20 bp smaller than before 
digestion, as expected, resulting in a 130 bp fragment 
(Fig. 2A lane 2).  After gel purification, the digested 
fragment was ligated to the 5’-phosphorylated siRNA-
loop-1. Although ligation reactions are normally carried 
out at room temperature, or at 14-16°C, we carried the 
reaction out at 4°C overnight, due to the relatively small 
size of the loop. Under this condition, successful ligation 
was achieved because the 130 bp band was completely 
shifted to ~145 bp (Fig. 2B, lane 4). Since the Bcc I-
digested fragment generated a G overhang at the 
digested end, this prevented end-end ligation of two 
molecules of the same species, thus, enhancing the 
ligation of siRNA-loop-1 and H1 promoter. 
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Fig. 2: Generation of p53-shRNA. The same strategy described in Fig. 1 was used to construct p53-shRNA. A: PCR and Bcc I digestion. PCR amplification 
yielded a 150 bp band (lane 1) and digestion of the PCR product with Bcc I shifted the band to 130 bp (lane 2). B: Ligation. Bcc I-digested DNA fragment 
was ligated to siRNA-loop-1 at 4°C overnight. Lane 3, before ligation; lane 4, after ligation. C: Extension. Ligated DNA fragment was treated with the 
nicking enzyme N.Alw I and then extended by Taq polymerase in the presence of dNTPs. Lanes 5, before nicking; 6, after nicking; 7, after extension. The 
extended product was about 160 bp. D: Cloning. Plasmid DNA was isolated from five positive clones and then digested with BamH I and Kpn I. M, 25 bp 
DNA ladders. All gels are 2%. 
 
The ligated products were gel-purified and were then 
treated with N.Alw I to make a nick at its recognition 
site. The nicking did not change migration of the DNA 
fragment; both the unnicked product and the nicked 
product migrated at ~145 bp (Fig. 2C, lanes 5&6). 
However, following extension in the presence of Taq 
polymerase and dNTP at 72°C, we detected two DNA 
fragments (Fig. 2C, lane 7): the lower band (~ 145 bp) co-
migrated with the one without extension (Fig. 2C, lane 6) 
and the upper band (~160 bp) was about 15 bp larger 
than the lower band. PCR cloning and sequencing 
analysis indicated that the upper band was a truly 
extended product containing the ligated product of the 
Bcc I-digested fragment with siRNA-loop-1. The lower 
band was not clonable and was believed to be non-
extended product presumably resulting from incomplete 
nicking. Alternatively, there is a possibility that a nick is 
made at the bottom strand, because the N.Alw I 
recognition sequence (GGATC) is also present at the 
bottom strand. Hence, the filling by Taq polymerase did 
not yield any extension. To clone the extended product, 
we gel-purified the upper band, subsequently digested it 
with BamH I, and finally ligated it to pSK-H1-Pu-X that 
had been digested with both BamH I and Xcm I. After 
the ligated DNA was introduced into E. coli cells, 
miniprep combined with restriction digestion showed 
that eight of ten randomly picked clones carried a 75 bp 
insert after digestion with BamH I and Kpn I. We used 
Kpn I here instead of Xcm I because the Xcm I site was 
eliminated after ligation (see Fig. 1). A result of 
restriction digestions for five of the eight positive clones 
is shown in Fig. 2D. Subsequent DNA sequencing 
confirmed that all five clones carried the right inserts, as 
expected. 
 
To determine whether the p53-shRNA construct (p53-
shRNA/pSK-H1-Pu-X) can generate functional siRNA to 
suppress p53 expression, we introduced p53-
shRNA/pSK-H1-Pu-X into MCF-7 cells that express wild 
type p53 (23). We also made a p53 shRNA construct 
using the same p53 specific sequence based on pSUPER 
vector previously described (8), to serve as a positive 
control (p53-shRNA-p).We found that p53-shRNA/pSK-
H1-Pu-X was able to inhibit the endogenous p53 
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expression, with over 80% suppression compared to the 
vector control (Fig. 3, lane 2). This was about comparable 
to that of the positive control p53-shRNA-p (Fig. 2, lane 
3), suggesting that the p53 shRNA constructed through 
this presently described approach is functional.  
 
Next, we examined the effect o f  l o o p  s i z e  i n  t h e  p 5 3 -
shRNA construct on the silencing efficiency. The loop in 
the original construct, i.e., p53-shRNA/pSK-H1-Pu-X 
( F i g .  2 D ) ,  w a s  2 1  b p ,  w h i c h  w a s  l a r g e r  t h a n  t h o s e  
commonly used loops. We first digested the clone with 
Xho I and then allowed it to be self-ligated. Since the Xho 
I site (CTCGAG) alone was successfully used as a loop to 
generate functional siRNAs (9), the construct generated 
by Xho I digestion and self-ligation is believed to be able 
to produce functional siRNAs. Compared to the original 
p53-shRNA/pSK-H1-Pu-X, the modified construct (p53-
shRNA/pSK-H1-Pu-X/Xho I) caused a slightly higher 
suppression of p53 expression (Fig. 3, lane 4), suggesting 
that the larger loop (21 bp) may interfere with the gene 
silencing efficiency to some extent, but this interference 
seems to be marginal. Therefore, removal of siRNA-loop-
1  d u r i n g  c o n s t r u c t i o n  o f  a n  s h R N A  l i b r a r y  c a n  b e  
eliminated, given that p53-shRNA with the 21-bp loop 
yielded over 80% of gene silencing efficiency. 
 
After validation of this method, we decided to generate 
shRNAs from partially randomized oligonucleotides 
f o l l o w i n g  t h e  p r o c e d u r e  i n  F i g .  1 .  T o  r e d u c e  t h e  
complexity, we designed an oligonucleotide primer 
carrying GNANNNNNNTNNHWWWWWA (sense 
strand), where H = A+C+T and W = A+T based on the 
general guidelines suggested by Reynolds et al. (16) and 
Ui-Tei et al. (17) combined with our own experience. We 
sequenced 15 of over 10,000 clones and found that all 15 
clones have unique sequences in the randomized region 
(Fig. 4), demonstrating the random nature of this pooled 
shRNAs.
 
 
Fig. 3: Suppression of p53 by p53-shRNA. A: Detection of p53 expression by Western blot. Plasmid carrying an appropriate DNA fragment was introduced 
into MCF-7 cells. Proteins samples were prepared as described in Materials and Methods. Lanes 1, vector control; 2, p53-shRNA/pSK-H1-Pu-X; 3, p53-
shRNA-p (positive control) and 4, p53-shRNA/pSK-H1-Pu-X/Xho I. β-actin serves as a loading control. B: Removal of siRNA-loop-1 in p53-shRNA. Both 
constructs were digested with BamH I and Kpn I. M, 25 bp DNA ladders; lanes 1, p53-shRNA/pSK-H1-Pu-X; 2, p53-shRNA/pSK-H1-Pu-X/Xho I. C: 
Sequence comparison of p53-shRNA/pSK-H1-Pu-X and p53-shRNA/pSK-H1-Pu-X/Xho I. The p53 specific sequence is underlined. 
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It has been reported that randomized siRNAs can be 
made from randomized oligonucleotides through the 
d o u b l e  p r o m o t e r  s y s t e m  ( 1 1 ,  1 3 ) .  H o w e v e r ,  g e n e  
silencing efficiency for siRNAs derived from the two 
promoter system is not as high as the shRNAs from the 
single promoter system, especially at the lower 
concentrations (25-27). This could be a problem for stable 
transfectants where usually a single copy of the cloned 
sequence is present in each cell and thus, the gene 
silencing efficiency could be compromised. A possible 
explanation is that the single promoter system generates 
a single RNA molecule, which is easy to form a self-
complementary double-stranded structure. In contrast, 
the double promoter system generates two RNA 
molecules, one sense and another antisense. In order for 
these two RNA molecules to efficiently form a duplex, 
the amount of RNA molecules would be much higher 
than a single molecule.  
 
Fig. 4: Sequences of 15 randomly picked clones from the library. N=A or G 
or C or T; H = A or C or T;  W = A or T. 
 
To determine the effect of shRNA loop size on gene 
silencing, we compared the construct carrying the 
original size of loop (21 bp) with one carrying a smaller 
loop (6 bp). Since a commonly used loop is about 9 bases, 
a large loop in shRNAs is believed to interfere with the 
shRNA-induced gene silencing efficiency. Hence, such a 
large loop is removed by digestion with a restriction 
enzyme and then self-ligation (14, 15, 20). To determine 
whether this step is necessary to achieve efficient gene 
silencing in the present approach, we also eliminated the 
initial loop sequence by digesting the plasmid with Xho 
I, followed by self-ligation. Our results indicate only a 
slight increase in suppressing p53 expression by the p53 
shRNA construct carrying a small loop. In fact, this result 
is also consistent with a report that an shRNA with a 23 
base loop is not different from one with a 9 base loop in 
suppressing the luciferase gene (25). This could be 
explained by the fact that Dicer processes the dsRNA 
stepwise from the terminus (28). Therefore, we suggest 
that it is not necessary to remove the original loop during 
construction of randomized shRNA libraries. 
 
Until now, methods for construction of shRNA libraries 
are based on either known sequences for individual 
genes (19, 24) or sequences derived from mixed cDNAs 
or cDNA libraries (14, 15, 20). While cDNA-based 
shRNA libraries provide a good alternative to 
individually made gene-specific shRNA libraries in 
terms of costs, construction of such cDNA-based shRNA 
libraries can still be labor intensive. Furthermore, due to 
the nature of the cDNA library, these cDNA-based 
shRNA libraries could have several limitations including 
the unequal representation of genes in a cDNA library. In 
addition, when restriction enzymes are used to generate 
small cDNA fragments, some of the sequences might be 
missed because of their uneven distributions in the 
sequences. 
 
Although it is generally believed that siRNA-mediated 
gene silencing is a posttranscriptional event, it has been 
recently shown that siRNAs can also induce 
transcriptional gene silencing (1, 2). While the 
mechanism of siRNA-induced transcriptional gene 
silencing is not fully understood, it is clear that the 
promoter regions are also targets for siRNAs. Since the 
shRNA libraries derived from randomized 
oligonucleotides could carry promoter-specific siRNA 
sequences, such libraries would offer another advantage 
over the cDNA-based shRNA libraries that target only 
cDNA sequences. 
 
In summary, we have described a simple approach to 
generate shRNAs, which can be used to construct a 
randomized shRNA library. This approach should be 
easily applied to viral vectors so that shRNAs can be 
used to infect virtually any type of cells with high 
efficiency. Given the wide use of siRNA technology to 
evaluate gene function, the randomized shRNA library 
will facilitate studies of gene function in human and 
mice, as well as other organisms. The method described 
in this study will also stimulate improvement of siRNA 
technology and development of its new applications.   
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